JSSH
UTHR icon

J. Safra Sarasin Holding’s United Therapeutics UTHR Stock Holding History

J. Safra Sarasin Holding’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Buy
1,106
+476
+76% +$268K 0.01% 498
2026
Q1 		$374K Hold
630
– – 0.01% 438
2025
Q4 		$307K Buy
630
+50
+9% +$23.3K 0.01% 459
2025
Q3 		$243K Buy
+580
New +$195K ﹤0.01% 454

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

J. Safra Sarasin Holding's UTHR Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its United Therapeutics (UTHR) stake by 76% in Q2 2026, buying an estimated $268K and bringing the position to 1,106 shares worth $631K. The position accounts for 0.01% of the portfolio, ranked #498.

J. Safra Sarasin Holding first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • J. Safra Sarasin Holding held 1,106 shares of United Therapeutics worth $631K as of Q2 2026.
  • J. Safra Sarasin Holding bought 476 United Therapeutics shares in Q2 2026, an estimated $268K.
  • United Therapeutics made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #498 holding.
  • J. Safra Sarasin Holding first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.